Skip to main content
logo
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
27.98
+1.15 (4.29%)
At close: Nov 6, 2026, 4:00 PM EST
27.51
-0.47 (-1.68%)
After-hours: Nov 6, 2026, 7:30 PM EST

Adaptive Biotechnologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-70.52-59.5-159.49-225.25-200.19-207.28
Depreciation & Amortization
15.3317.8319.2622.2320.9213.95
Asset Writedown & Restructuring Costs
0.35-7.2125.43--
Loss (Gain) From Sale of Investments
-1.18-2.51-8.21-9.180.747.23
Stock-Based Compensation
46.1551.4853.6162.9155.4843.25
Other Operating Activities
22.144.489.8713.7310.656.93
Change in Accounts Receivable
-21.85-8.65-3.742.03-22.65-7.36
Change in Inventory
-0.28-15.37-2.840.82-5.2
Change in Accounts Payable
-0.120.670.67-5.417.113.94
Change in Unearned Revenue
17.86-36.75-10.48-29.29-56.5-57.73
Change in Other Net Operating Assets
-12.17-12.04-9.28-10.68-0.339.53
Operating Cash Flow
-4.28-45.99-95.21-156.32-183.95-192.73
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4.55-2.96-3.66-10.7-16.35-61.75
Investment in Securities
-163.140.9181.46140.3419.25242.96
Investing Cash Flow
-167.6537.9577.79129.652.91181.21

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
56.3930.40.242.257.8926.72
Other Financing Activities
-25.6---124.380.43
Financing Cash Flow
192.5230.40.242.25132.2727.15

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
20.622.37-17.18-24.43-48.7815.63

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-8.82-48.95-98.88-167.02-200.29-254.47
Free Cash Flow Growth
------
Free Cash Flow Margin
-2.96%-17.67%-55.25%-98.09%-108.09%-164.87%
Free Cash Flow Per Share
-0.06-0.32-0.67-1.16-1.41-1.81
Levered Free Cash Flow
14.430.95-24.48-81.95-90.17-139.1
Unlevered Free Cash Flow
20.088.31-17.24-73.33-87.53-139.1

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
20.6612.648.868.990.49-
Change in Working Capital
-16.55-57.77-17.45-46.18-71.55-56.82
SEC Filings: 10-K · 10-Q